FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 45 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $66,000 | +22.2% | 19,760 | +11.1% | 0.00% | – |
| Q3 2019 | $54,000 | +28.6% | 17,783 | +0.3% | 0.00% | – |
| Q2 2019 | $42,000 | -44.7% | 17,724 | -12.4% | 0.00% | – |
| Q1 2019 | $76,000 | +7.0% | 20,223 | +2.4% | 0.00% | – |
| Q4 2018 | $71,000 | +9.2% | 19,752 | +75.1% | 0.00% | – |
| Q3 2018 | $65,000 | +22.6% | 11,278 | +6.1% | 0.00% | – |
| Q2 2018 | $53,000 | +20.5% | 10,632 | +24.0% | 0.00% | – |
| Q1 2018 | $44,000 | -8.3% | 8,575 | +7.1% | 0.00% | – |
| Q4 2017 | $48,000 | -23.8% | 8,003 | -29.5% | 0.00% | – |
| Q3 2017 | $63,000 | +26.0% | 11,351 | +4.7% | 0.00% | – |
| Q2 2017 | $50,000 | -9.1% | 10,844 | -2.3% | 0.00% | – |
| Q1 2017 | $55,000 | -55.3% | 11,101 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $123,000 | -10.2% | 11,101 | -25.2% | 0.00% | 0.0% |
| Q3 2016 | $137,000 | +45.7% | 14,831 | +0.4% | 0.00% | – |
| Q2 2016 | $94,000 | -5.1% | 14,776 | -2.8% | 0.00% | -100.0% |
| Q1 2016 | $99,000 | -19.5% | 15,202 | +0.6% | 0.00% | 0.0% |
| Q4 2015 | $123,000 | +29.5% | 15,114 | +17.2% | 0.00% | 0.0% |
| Q3 2015 | $95,000 | – | 12,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $24,530,000,000 | 3.64% |
| Opaleye Management Inc. | 950,000 | $4,873,000 | 1.39% |
| DSC Advisors, L.P. | 1,187,604 | $6,092,000 | 1.28% |
| DAFNA Capital Management LLC | 335,500 | $1,721,000 | 0.84% |
| Vivo Capital, LLC | 855,000 | $4,386,000 | 0.62% |
| Stonepine Capital Management, LLC | 129,756 | $666,000 | 0.36% |
| Eversept Partners, LP | 107,500 | $551,475 | 0.26% |
| Tekla Capital Management LLC | 930,398 | $4,773,000 | 0.19% |
| Perceptive Advisors | 1,117,324 | $5,732,000 | 0.16% |
| Crestline Management, LP | 217,670 | $1,117,000 | 0.14% |